Presentation Information
[1-MO4-4]Prediction of therapeutic efficacy of Lu-PSMA targeted therapy for mCRPC based on SUVmean
Atsuya Okada1、Hidetoshi Kuruma2,3、Kenta Miki2,4、Chieko Okazaki2、Naomi Morita1、Naoki Mihara1、Youhei Fujii1、Risa Momoi1、Takayuki Nakamura1、Teruo Yamamoto1、Akira Kida1 (1.Jinsenkai Medical Corp. MI Clinic、2.Theranostics Yokohama、3.Bashamichi-Sakura Clinic, Yokohama, Japan、4.The Jikei University of Medecine, Tokyo, Japan)